UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CA-069: Prise en charge thérapeutique des patients diabétique de type 2 en France

Diabetes & metabolism, 2016-03, Vol.42, p.A53-A54

2016

Volltextzugriff (PDF)

CO-04: Coût du diabète de type 2 en France

Diabetes & metabolism, 2016-03, Vol.42, p.A2-A2

2016

Volltextzugriff (PDF)

Treatment Maintenance Duration of Dual Therapy with Metformin and Sitagliptin in Type 2 Diabetes – Real-World Data From Odyssee Study

Value in health, 2014-11, Vol.17 (7), p.A334-A335

2014

Volltextzugriff (PDF)

Pooled analysis of individual patient data from European observational studies on zonisamide use in clinical practice: Sub-group comparisons of efficacy

Journal of the neurological sciences, 2013-10, Vol.333, p.e21-e21

2013

Volltextzugriff (PDF)

HTA138 Impact of Publication of the French Commission for Economic and Public Health Evaluation (CEESP) Doctrine on French Medico-Economic Evaluation – a Quantitatve Analysis

Value in health, 2023-12, Vol.26 (12), p.S345

2023

Volltextzugriff (PDF)

P17 Can You Design and Conduct a Real-World Evidence Study That Is Transferable Between HTA Bodies?

Value in health, 2022-12, Vol.25 (12), p.S4-S5

2022

Volltextzugriff (PDF)

HPR27 Is It Possible to Anticipate the Risk of Major Reservation Issued by the CEESP? A Retrospective Analysis of Published Opinions

Value in health, 2022-12, Vol.25 (12), p.S237-S237

2022

Volltextzugriff (PDF)

HTA215 Comparison of French HTA Parallel Appraisal Performed by the Economic and Public Health Committee (CEESP) and the Transparency Committee (TC) for a Same Product: Are the Conclusions of the Two Committees Consistent?

Value in health, 2022-12, Vol.25 (12), p.S339-S339

2022

Volltextzugriff (PDF)

HTA96 Health Economic Modelling for HTA Assessment: A Comparison of Economic Protocols Submitted to Three HTA Bodies (HAS, NICE, CADTH)

Value in health, 2022-12, Vol.25 (12), p.S314-S315

2022

Volltextzugriff (PDF)

Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data

The Lancet (British edition), 2007-01, Vol.369 (9556), p.115-122

2007

Volltextzugriff (PDF)

SA64 Systematic Literature Review of Measurement and Valuation Methods for Societal Costs: A Focus on Cost-Effectiveness Analyses of Three Types of Disease Potentially Associated with High Spillover Effects

Value in health, 2023-12, Vol.26 (12), p.S554

2023

Volltextzugriff (PDF)

EE259 The Societal Cost of Age-Related Macular Degeneration and Diabetic Macular Edema: An Estimation Using a Pragmatic Literature Review

Value in health, 2023-12, Vol.26 (12), p.S101

2023

Volltextzugriff (PDF)

HTA24 Adopting a Societal Perspective in Health-Economic Evaluation: A Review of 9 HTA Methodological Guidelines on How to Integrate Societal Costs

Value in health, 2024-06, Vol.27 (6), p.S248-S248

2024

Volltextzugriff (PDF)

HTA22 ITC Appraisal by French HTA Committees: Comprehensive Review and Comparison

Value in health, 2022-12, Vol.25 (12), p.S300-S300

2022

Volltextzugriff (PDF)

EE363 Cost-Effectiveness Analysis of Adding Tumor Treating Fields Therapy to Temozolomide Versus Temozolomide Only in Patients with Glioblastoma in France

Value in health, 2023-12, Vol.26 (12), p.S121

2023

Volltextzugriff (PDF)

EE668 Cost-Effectiveness of Pembrolizumab as an Adjuvant Treatment for Adults and Adolescents Aged 12 Years and Older With Resected Stage IIB/IIC Melanoma in France

Value in health, 2023-12, Vol.26 (12), p.S182

2023

Volltextzugriff (PDF)

POSA110 Cost-Effectiveness Analysis of Pembrolizumab Versus Brentuximab Vedotin (BV) in Adult and Paediatric Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma in France

Value in health, 2022-01, Vol.25 (1), p.S55-S55

2022

Volltextzugriff (PDF)

EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study

Journal of medical Internet research, 2019-01, Vol.21 (1), p.e10178-e10178

2019

Volltextzugriff (PDF)

Does adherence to inhaled corticosteroids predict asthma-related outcomes over time? A cohort study

The European respiratory journal, 2019-12, Vol.54 (6), p.1900901

2019

Volltextzugriff (PDF)

Assessing fitness to drive in the elderly and those with medical conditions: guidelines should specify methods and evidence

Injury prevention, 2014-06, Vol.20 (3), p.210-212

2014

Volltextzugriff (PDF)

Cost of Type 2 Diabetes According to Glucose-Lowering Medications in France

Value in health, 2015-11, Vol.18 (7), p.A604-A604

2015

Volltextzugriff (PDF)

Patterns of Pharmacological Treatment in Type 2 Diabetes in France in 2013

Value in health, 2015-11, Vol.18 (7), p.A599-A599

2015

Volltextzugriff (PDF)

PDB14 - Patterns of Pharmacological Treatment in Type 2 Diabetes in France in 2013

Value in health, 2015-11, Vol.18 (7), p.A599-A599

2015

Volltextzugriff (PDF)

PCV49 - Incidence of Cardiovascular Events Following Myocardial Infarction in France: an Observational Analysis Using a Claims Database

Value in health, 2015-11, Vol.18 (7), p.A382-A382

2015

Volltextzugriff (PDF)

PCV72 - Increased Costs Due To Myocardial Infarction (Mi) In France: An Observational Analysis Using A Claims Database

Value in health, 2015-11, Vol.18 (7), p.A386-A386

2015

Volltextzugriff (PDF)

1 – 25 von 138

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(127)
Mit Volltextzugriff
(119)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(59)
Life Sciences & Biomedicine
(47)
Humans
(39)
Biochemistry & Molecular Biology
(16)
Biological And Medical Sciences
(15)
Genomics
(14)
Dna
(13)
Biotechnology & Applied Microbiology
(12)
Fundamental And Applied Biological Sciences. Psychology
(12)
Life Sciences
(11)
Deoxyribonucleic Acid
(10)
Genetics & Heredity
(10)
Internal Medicine
(10)
Multidisciplinary Sciences
(10)
Reproducibility Of Results
(10)
Science & Technology - Other Topics
(10)
Sequence Analysis, Dna - Methods
(10)
Dna Sequencing
(9)
Female
(9)
Genes
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

CA-069: Prise en charge thérapeutique des patients diabétique de type 2 en France

CO-04: Coût du diabète de type 2 en France

Treatment Maintenance Duration of Dual Therapy with Metformin and Sitagliptin in Type 2 Diabetes – Real-World Data From Odyssee Study

Pooled analysis of individual patient data from European observational studies on zonisamide use in clinical practice: Sub-group comparisons of efficacy

HTA138 Impact of Publication of the French Commission for Economic and Public Health Evaluation (CEESP) Doctrine on French Medico-Economic Evaluation – a Quantitatve Analysis

P17 Can You Design and Conduct a Real-World Evidence Study That Is Transferable Between HTA Bodies?

HPR27 Is It Possible to Anticipate the Risk of Major Reservation Issued by the CEESP? A Retrospective Analysis of Published Opinions

HTA215 Comparison of French HTA Parallel Appraisal Performed by the Economic and Public Health Committee (CEESP) and the Transparency Committee (TC) for a Same Product: Are the Conclusions of the Two Committees Consistent?

HTA96 Health Economic Modelling for HTA Assessment: A Comparison of Economic Protocols Submitted to Three HTA Bodies (HAS, NICE, CADTH)

Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data

SA64 Systematic Literature Review of Measurement and Valuation Methods for Societal Costs: A Focus on Cost-Effectiveness Analyses of Three Types of Disease Potentially Associated with High Spillover Effects

EE259 The Societal Cost of Age-Related Macular Degeneration and Diabetic Macular Edema: An Estimation Using a Pragmatic Literature Review

HTA24 Adopting a Societal Perspective in Health-Economic Evaluation: A Review of 9 HTA Methodological Guidelines on How to Integrate Societal Costs

HTA22 ITC Appraisal by French HTA Committees: Comprehensive Review and Comparison

EE363 Cost-Effectiveness Analysis of Adding Tumor Treating Fields Therapy to Temozolomide Versus Temozolomide Only in Patients with Glioblastoma in France

EE668 Cost-Effectiveness of Pembrolizumab as an Adjuvant Treatment for Adults and Adolescents Aged 12 Years and Older With Resected Stage IIB/IIC Melanoma in France

POSA110 Cost-Effectiveness Analysis of Pembrolizumab Versus Brentuximab Vedotin (BV) in Adult and Paediatric Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma in France

EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study

Does adherence to inhaled corticosteroids predict asthma-related outcomes over time? A cohort study

Assessing fitness to drive in the elderly and those with medical conditions: guidelines should specify methods and evidence

Cost of Type 2 Diabetes According to Glucose-Lowering Medications in France

Patterns of Pharmacological Treatment in Type 2 Diabetes in France in 2013

PDB14 - Patterns of Pharmacological Treatment in Type 2 Diabetes in France in 2013

PCV49 - Incidence of Cardiovascular Events Following Myocardial Infarction in France: an Observational Analysis Using a Claims Database

PCV72 - Increased Costs Due To Myocardial Infarction (Mi) In France: An Observational Analysis Using A Claims Database

Suchergebnisse filtern